<DOC>
	<DOCNO>NCT00865904</DOCNO>
	<brief_summary>The primary objective study evaluate safety tolerability VX-809 participant cystic fibrosis ( CF ) homozygous F508del mutation CF transmembrane conductance regulator ( CFTR ) gene .</brief_summary>
	<brief_title>Study VX-809 Cystic Fibrosis Subjects With ∆F508-CFTR Gene Mutation</brief_title>
	<detailed_description>This Phase 2 , randomize , double-blind , placebo-controlled , multiple-dose study orally-administered VX-809 participant CF homozygous specific CFTR mutation know ∆F508 F508del . Enrollment plan 90 participant approximately 20 center . Participants plan randomized 4:1 ratio receive 1 4 dos VX-809 placebo day 28 day parallel design . Participants outpatient study , except overnight stay Day 1 28 .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Confirmed diagnosis CF ∆F508CFTR mutation allele Forced expiratory volume 1 second ( FEV1 ) great equal ( &gt; = ) 40 percent ( % ) predict normal age , gender , height Weight &gt; =40 kilogram ( kg ) body mass index great equal 18.5 kilogram per square meter ( kg/m^2 ) Screening laboratory value , test , physical examination within acceptable range Negative pregnancy test ( woman childbearing potential ) Able willing follow contraceptive requirement Willing remain stable medication regimen duration study participation History illness , ongoing acute illness , could impact safety study participant may confound result study Pulmonary exacerbation change therapy pulmonary disease within 14 day receive first dose study drug Impaired hepatic renal function History organ hematological transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>∆F508</keyword>
	<keyword>F508del</keyword>
	<keyword>Cystic Fibrosis Transmembrane Conductance Regulator</keyword>
	<keyword>CFTR</keyword>
	<keyword>Pancreatic disease</keyword>
	<keyword>Lung disease</keyword>
	<keyword>Genetic disease , inborn</keyword>
	<keyword>Infant , newborn , disease</keyword>
</DOC>